Dietary macro/micronutritional compositions and applications thereof
Provided herein are compositions composed of a plurality of minerals and vitamins that provide numerous health benefits and quality of life to subjects in need thereof. Also described herein are kits composed of the compositions described herein with a marine omega 3 fatty acid, coenzyme Q10, or a combination thereof. In one aspect, the compositions described herein can treat a subject diagnosed with prediabetes, type 1 diabetes, type 2 diabetes or insulin uptake. In another aspect, the compositions described herein can increase the performance of athletes by relaxing and dilating blood vessels, thus improve circulation as well as shorten the time of recovery after exercises or games. In another aspect, the compositions described herein can improve the well-being and immune response system. It also improves the human system against bacterial and fungal infections. In another aspect, the compositions described herein can treat myalgic encephalomyelitis in a subject. In another aspect, the compositions described herein can reduce or prevent one or more symptoms of Crohn's disease in a subject. In another aspect, the compositions described herein can enhance one or more physical properties of a subject after exercise.
1 . A method for treating a subject with type I diabetes or type II diabetes or a subject diagnosed with prediabetes, the method comprising administering to the subject a therapeutically effective amount of a composition comprising:
vitamin B1,
vitamin B2,
vitamin B3,
vitamin B5,
vitamin B6,
vitamin B7,
vitamin B9,
vitamin B12,
vitamin C,
vitamin D 3 ,
a pharmaceutically-acceptable compound of calcium,
a pharmaceutically-acceptable compound of magnesium,
a pharmaceutically-acceptable compound of zinc,
a pharmaceutically-acceptable compound of selenium,
a pharmaceutically-acceptable compound of iron, and
a pharmaceutically-acceptable compound of L-carnitine,
wherein the composition does not include vitamin E.
2 . A method for treating a subject with type I diabetes or type II diabetes or a subject diagnosed with prediabetes, the method comprising administering to the subject a therapeutically effective amount of a composition comprising:
vitamin B1,
vitamin B2,
vitamin B3,
vitamin B5,
vitamin B6,
vitamin B7,
vitamin B9,
vitamin B12,
vitamin C,
vitamin D 3 ,
a pharmaceutically-acceptable compound of calcium,
a pharmaceutically-acceptable compound of magnesium,
a pharmaceutically-acceptable compound of zinc,
a pharmaceutically-acceptable compound of selenium,
a pharmaceutically-acceptable compound of iron, and
a pharmaceutically-acceptable compound of L-carnitine,
a pharmaceutically-acceptable compound of cobalt,
red beetroot extract, and a pectin.
3 . The method of claim 1 , wherein the composition treats one or more symptoms of type I diabetes or type II diabetes when compared to the same subject prior to the administration of the composition, wherein the symptom is selected from the group consisting of weight loss, polydipsia, polyuria, polyphagia, blurred vision, headache, fatigue, slow healing of cuts, itchy skin, and any combination thereof.
4 . The method of claim 1 , wherein the composition reduces the amount of insulin required by the subject.
5 . The method of claim 1 , wherein the composition further comprises red beetroot extract and a pectin.
6 . The method of claim 1 , wherein the pectin comprises sugarbeet pectin.
7 . The method of claim 1 , wherein the composition further comprises a pharmaceutically-acceptable compound of chromium and a pectin.
8 . The method of claim 7 , wherein the pectin comprises sugarbeet pectin.
9 . The method of claim 1 , wherein the composition further comprises
a therapeutically effective amount of
a pharmaceutically-acceptable compound of manganese,
a pharmaceutically-acceptable compound of chromium,
a pharmaceutically-acceptable compound of copper, and reduced glutathione.
10 . The method of claim 1 , wherein the subject is further administered a marine omega 3 fatty acid, coenzyme Q10, or a combination thereof.
11 . The method of claim 1 , wherein the composition comprises vitamin B1 in an amount of from about 0.005 weight percent to about 0.10 weight percent of the composition;
vitamin B2 in an amount of from about 0.005 weight percent to about 0.10 weight percent of the composition;
vitamin B3 in an amount of from about 0.05 weight percent to about 0.50 weight percent of the composition;
vitamin B5 in an amount of from about 0.01 weight percent to about 0.50 weight percent of the composition;
vitamin B6 in an amount of from about 0.01 weight percent to about 0.50 weight percent of the composition;
vitamin B7 in an amount of from about 0.010 weight percent to about 0.50 weight percent of the composition;
vitamin B9 in an amount of from about 0.001 weight percent to about 0.10 weight percent of the composition;
vitamin B12 in an amount of from about 0.05 weight percent to about 0.50 weight percent of the composition;
vitamin C in an amount of from about 1.00 weight percent to about 10.00 weight percent of the composition;
vitamin D3 in an amount of from about 0.01 weight percent to about 0.50 weight percent of the composition;
a pharmaceutically-acceptable compound of calcium in an amount of from about 10.00 weight percent to about 35.00 weight percent of the composition;
a pharmaceutically-acceptable compound of magnesium in an amount of from about 15.00 weight percent to about 35.00 weight percent of the composition;
a pharmaceutically-acceptable compound of zinc in an amount of from about 0.10 weight percent to about 2.00 weight percent of the composition;
a pharmaceutically-acceptable compound of selenium in an amount of from about 0.01 weight percent to about 0.50 weight percent of the composition;
a pharmaceutically-acceptable compound of iron in an amount of from about 0.05 weight percent to about 5.00 weight percent of the composition; and
a pharmaceutically-acceptable compound of L-carnitine in an amount of from about 10.00 weight percent to about 30.00 weight percent of the composition.
12 . The method of claim 1 , wherein the composition comprises
vitamin B1 in an amount of from about 0.50 weight percent to about 3.00 weight percent of the composition;
vitamin B2 in an amount of from about 0.50 weight percent to about 3.00 weight percent of the composition;
vitamin B3 in an amount of from about 1.00 weight percent to about 3.00 weight percent of the composition;
vitamin B5 in an amount of from about 0.10 weight percent to about 2.00 weight percent of the composition;
vitamin B6 in an amount of from about 0.10 weight percent to about 2.00 weight percent of the composition;
vitamin B7 in an amount of from about 0.10 weight percent to about 3.00 weight percent of the composition;
vitamin B9 in an amount of from about 0.01 weight percent to about 0.10 weight percent of the composition;
vitamin B12 in an amount of from about 1.00 weight percent to about 10.00 weight percent of the composition;
vitamin C in an amount of from about 1.00 weight percent to about 10.00 weight percent of the composition;
vitamin D3 in an amount of from about 0.10 weight percent to about 1.00 weight percent of the composition;
a pharmaceutically-acceptable compound of calcium in an amount of from about 15.00 weight percent to about 25.00 weight percent of the composition;
a pharmaceutically-acceptable compound of magnesium in an amount of from about 5.00 weight percent to about 15.00 weight percent of the composition;
a pharmaceutically-acceptable compound of zinc in an amount of from about 1.00 weight percent to about 5.00 weight percent of the composition;
a pharmaceutically-acceptable compound of selenium in an amount of from about 0.10 weight percent to about 2.00 weight percent of the composition;
a pharmaceutically-acceptable compound of iron in an amount of from about 5.00 weight percent to about 20.00 weight percent of the composition;
a pharmaceutically-acceptable compound of L-carnitine in an amount of from about 10.00 weight percent to about 25.00 weight percent of the composition;
a pharmaceutically-acceptable compound of manganese in an amount of from about 0.10 weight percent to about 1.00 weight percent of the composition;
a pharmaceutically-acceptable compound of chromium in an amount of from about 0.001 weight percent to about 0.10 weight percent of the composition;
a pharmaceutically-acceptable compound of copper in an amount of from about 0.10 weight percent to about 2.00 weight percent of the composition; and
glutathione or pharmaceutically-acceptable salt thereof in an amount of from about 5.00 weight percent to about 20.00 weight percent of the composition.
13 . A method for treating a subject with type | diabetes or type II diabetes or a subject diagnosed with prediabetes, the method comprising administering to the subject a therapeutically effective amount of a composition comprising:
vitamin B1 in an amount of from about 0.005 weight percent to about 0.10 weight percent of the composition;
vitamin B2 in an amount of from about 0.005 weight percent to about 0.10 weight percent of the composition;
vitamin B3 in an amount of from about 0.05 weight percent to about 0.50 weight percent of the composition;
vitamin B5 in an amount of from about 0.01 weight percent to about 0.50 weight percent of the composition;
vitamin B6 in an amount of from about 0.01 weight percent to about 0.50 weight percent of the composition;
vitamin B7 in an amount of from about 0.010 weight percent to about 0.50 weight percent of the composition;
vitamin B9 in an amount of from about 0.001 weight percent to about 0.10 weight percent of the composition;
vitamin B12 in an amount of from about 0.05 weight percent to about 0.50 weight percent of the composition;
vitamin C in an amount of from about 1.00 weight percent to about 10.00 weight percent of the composition;
vitamin D3 in an amount of from about 0.01 weight percent to about 0.50 weight percent of the composition;
a pharmaceutically-acceptable compound of calcium in an amount of from about 10.00 weight percent to about 35.00 weight percent of the composition;
a pharmaceutically-acceptable compound of magnesium in an amount of from about 15.00 weight percent to about 35.00 weight percent of the composition;
a pharmaceutically-acceptable compound of zinc in an amount of from about 0.10 weight percent to about 2.00 weight percent of the composition;
a pharmaceutically-acceptable compound of selenium in an amount of from about 0.01 weight percent to about 0.50 weight percent of the composition;
a pharmaceutically-acceptable compound of iron in an amount of from about 0.05 weight percent to about 5.00 weight percent of the composition; and
a pharmaceutically-acceptable compound of L-carnitine in an amount of from about 10.00 weight percent to about 30.00 weight percent of the composition.
14 . A method for treating a subject with type I diabetes or type II diabetes or a subject diagnosed with prediabetes, the method comprising administering to the subject a therapeutically effective amount of a composition comprising:
vitamin B1 in an amount of from about 0.50 weight percent to about 3.00 weight percent of the composition;
vitamin B2 in an amount of from about 0.50 weight percent to about 3.00 weight percent of the composition;
vitamin B3 in an amount of from about 1.00 weight percent to about 3.00 weight percent of the composition;
vitamin B5 in an amount of from about 0.10 weight percent to about 2.00 weight percent of the composition;
vitamin B6 in an amount of from about 0.10 weight percent to about 2.00 weight percent of the composition;
vitamin B7 in an amount of from about 0.10 weight percent to about 3.00 weight percent of the composition;
vitamin B9 in an amount of from about 0.01 weight percent to about 0.10 weight percent of the composition;
vitamin B12 in an amount of from about 1.00 weight percent to about 10.00 weight percent of the composition;
vitamin C in an amount of from about 1.00 weight percent to about 10.00 weight percent of the composition;
vitamin D3 in an amount of from about 0.10 weight percent to about 1.00 weight percent of the composition;
a pharmaceutically-acceptable compound of calcium in an amount of from about 15.00 weight percent to about 25.00 weight percent of the composition;
a pharmaceutically-acceptable compound of magnesium in an amount of from about 5.00 weight percent to about 15.00 weight percent of the composition;
a pharmaceutically-acceptable compound of zinc in an amount of from about 1.00 weight percent to about 5.00 weight percent of the composition;
a pharmaceutically-acceptable compound of selenium in an amount of from about 0.10 weight percent to about 2.00 weight percent of the composition;
a pharmaceutically-acceptable compound of iron in an amount of from about 5.00 weight percent to about 20.00 weight percent of the composition;
a pharmaceutically-acceptable compound of L-carnitine in an amount of from about 10.00 weight percent to about 25.00 weight percent of the composition;
a pharmaceutically-acceptable compound of manganese in an amount of from about 0.10 weight percent to about 1.00 weight percent of the composition;
a pharmaceutically-acceptable compound of chromium in an amount of from about 0.001 weight percent to about 0.10 weight percent of the composition;
a pharmaceutically-acceptable compound of copper in an amount of from about 0.10 weight percent to about 2.00 weight percent of the composition; and
glutathione or a pharmaceutically-acceptable salt thereof in an amount of from about 5.00 weight percent to about 20.00 weight percent of the composition.